True Leaf Brands Inc. (MJ) (CSE.MJ, OTC: TRLFF, Forum) has announced it has submitted an application to Health Canada for an amendment to its Standard Processing License for the Sale of Dried Cannabis.

The amended license will permit True Leaf to sell its craft cannabis products directly to medical patients and retail distributors nationwide.

Darcy Bomford, CEO of True Leaf, commented:

The Cannabis Society is pleased to announce that they are hosting a worldwide hybrid conference covering two distinct topics: European Medical Cannabis and North American MSO Growth and Consolidation on Tuesday, September 21st, 2021. This one-day conference will start with discussions surrounding European Medical Cannabis and move into North American MSO Growth and Consolidation in the afternoon. 

As recreational cannabis use increases, so has the number of calls regarding dogs who have accidentally consumed cannabis products

Photo by James Barker on Unsplash

In the past few years, opioids and cannabinoids have received a great deal of attention from the media and public health authorities.

New York, US, Aug. 24, 2021 (GLOBE NEWSWIRE) -- CBD Skincare Products Market Overview

According to a comprehensive research report by Market Research Future (MRFR), “CBD Skincare Products Market Information by Product Type, Category, Distribution Channel and Region - Forecast till 2028”, the market is projected to Grow at a 29.1% CAGR from 2021 to 2028.

Major Growth Boosters

Canadians looking for exponential gains can consider investing in the cannabis sector. Canada legalized marijuana for recreational use almost three years back, and now it’s quite possible for pot to be legalized at the federal level in the United States as well. However, while Canadian cannabis producers such as Aurora Cannabis (TSX:ACB)(NYSE:ACB) are struggling with lower-than-expected demand, negative profit margins, and a slew of other structural issues, their counterparts south of the border continue to grow at an enviable pace.

The Canadian cannabis market is forecast to grow from US$2.6 billion in 2020 to US$6.4 billion in 2026. Comparatively, the legal marijuana market in the U.S. is forecast to surpass US$40 billion in sales by the end of 2025.

Canopy Growth (TSX:WEED)(NYSE:CGC) is a world-leading, diversified cannabis and cannabinoid-based consumer products company with operations in countries across the world. The company produces, distributes, and sells a diverse range of cannabis and hemp-based products and other consumer products for both recreational and medical purposes under a portfolio of distinct brands in Canada. Canopy Growth sells products pursuant to the Cannabis Act, and globally pursuant to applicable international and Canadian legislation, regulations, and permits.

The Cannabis Council of Canada (C3) has launched an advocacy campaign to represent the interests of Canadian licensed producers ahead of the federal election on Sept. 20.

The campaign, titled #FutureofCanadianCannabis, will focus on advocating for criminal expungements, removing medical cannabis taxation and other priority issues concerning the cannabis industry.

“Our goal is to leverage the election period to encourage more license holders to develop lasting relationships with their local Member of Parliament and to help elected officials understand the benefits of legal cannabis for their communities and their constituents,” said C3 president and CEO, George Smitherman.

A recent study by public health researchers published in Drug and Alcohol Review documents the rapid expansion of the cannabis retail market in Canada in the two years following legalization.

Similar to the team's previous study 6 months after legalization, they found there were twice as many cannabis stores concentrated in low-income neighborhoods compared to high-income neighborhoods.